These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis]. Mizuno I; Yasui T; Takeyama H; Ishikawa M; Terada J; Mohri N; Ueda T; Sumita N; Kobayashi K; Akamo Y Gan To Kagaku Ryoho; 1995 Sep; 22(11):1598-601. PubMed ID: 7574769 [TBL] [Abstract][Full Text] [Related]
6. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients]. Fujiwara K; Yamauchi H; Sawada S; Koike H; Mohri H; Ohishi Y; Kohno I Gan To Kagaku Ryoho; 1992 Dec; 19(14):2373-9. PubMed ID: 1463344 [TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of liposome-entrapped carboplatin after intraperitoneal administration in rats]. Yasui T; Mizuno I; Ichino T; Akamo Y; Yamamoto T; Itabashi Y; Saito T; Kurahashi S; Tanimoto N; Yura J Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1753-5. PubMed ID: 1530349 [TBL] [Abstract][Full Text] [Related]
8. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors]. Shimizu A; Kimura T; Funatsu M; Hada Y; Tamura K; Taguchi A; Miyakawa Z; Notake Y Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer]. Ohno M; Hirokawa M; Hando T Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect. Rojbani H; Nyan M; Ohya K; Kasugai S J Biomed Mater Res A; 2011 Sep; 98(4):488-98. PubMed ID: 21681941 [TBL] [Abstract][Full Text] [Related]
12. [A case of malignant peritoneal mesothelioma successfully treated with carboplatin and paclitaxel]. Ogura O; Noguchi T; Nagata K; Noma H; Maemura M; Higashimoto M; Takebayashi Y; Maeda S Gan To Kagaku Ryoho; 2006 Jul; 33(7):1001-4. PubMed ID: 16835497 [TBL] [Abstract][Full Text] [Related]
13. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Los G; Smals OA; van Vugt MJ; van der Vlist M; den Engelse L; McVie JG; Pinedo HM Cancer Res; 1992 Mar; 52(5):1252-8. PubMed ID: 1737387 [TBL] [Abstract][Full Text] [Related]
14. Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat. Los G; Tuyt L; van Vugt M; Schornagel J; Pinedo HM Cancer Chemother Pharmacol; 1993; 32(6):425-33. PubMed ID: 8258189 [TBL] [Abstract][Full Text] [Related]
15. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer. Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987 [TBL] [Abstract][Full Text] [Related]
16. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma. Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613 [TBL] [Abstract][Full Text] [Related]
17. Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administration. Lindnér PG; Heath D; Howell SB; Naredi PL; Hafström LR Cancer Chemother Pharmacol; 1997; 40(5):444-8. PubMed ID: 9272123 [TBL] [Abstract][Full Text] [Related]
18. Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model. Jandial DD; Messer K; Farshchi-Heydari S; Pu M; Howell SB Gynecol Oncol; 2009 Dec; 115(3):362-6. PubMed ID: 19775736 [TBL] [Abstract][Full Text] [Related]
19. Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration. Nyan M; Sato D; Kihara H; Machida T; Ohya K; Kasugai S Clin Oral Implants Res; 2009 Mar; 20(3):280-7. PubMed ID: 19397639 [TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model. Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]